Price target
76.00DGBX+20.00+35.71%
The 7 analysts offering 1 year price forecasts for DR. MARTENS PLC ORD GBP0.01 have a max estimate of 102.0 and a min estimate of 55.00.
Analyst rating
Based on 7 analysts giving stock ratings to DR. MARTENS PLC ORD GBP0.01 in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
1
Buy
0
Hold
6
Sell
0
Strong sell
0
EPS
Forecast
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
−0.04
0.00
0.04
0.07
0.11
Reported
Estimate
Currency: GBP
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
Reported
0.08
0.02
0.05
−0.01
—
—
Estimate
0.10
0.02
0.05
−0.02
0.03
—
Surprise
−13.97%
0.00%
−5.56%
+39.81%
—
—
Revenue
Forecast
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
0.00
150.00 M
300.00 M
450.00 M
600.00 M
Reported
Estimate
Currency: GBP
H1 '21
H2 '21
H1 '22
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
Reported
581.85 M
395.80 M
481.30 M
324.60 M
—
—
Estimate
580.84 M
398.40 M
493.87 M
324.60 M
480.39 M
—
Surprise
+0.17%
−0.65%
−2.54%
0.00%
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
DOCS EPS for the last quarter is −0.01 GBX despite the estimation of −0.02 GBX. In the next quarter EPS is expected to reach 0.03 GBX. Track more of DR. MARTENS PLC ORD GBP0.01 financials and stay on top of what is up with the company.
In the next quarter DR. MARTENS PLC ORD GBP0.01 revenue is expected to reach 480.39 M GBX. Check out DR. MARTENS PLC ORD GBP0.01 revenue and earnings and make informed decisions.
According to analysts, DOCS price target is 76.00 GBX with a max estimate of 102.00 GBX and a min estimate of 55.00 GBX. Check if this forecast comes true in a year, meanwhile watch DR. MARTENS PLC ORD GBP0.01 stock price chart and keep track of the current situation with DOCS news and stock market news.
We've gathered opinions of 7 analysts rating DOCS stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.